STOCK TITAN

Novartis AG (NVS) Net Income by Year

NVS

Novartis AG reported $14.0B in net income in fiscal year 2025. This represents an increase of 17.0% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Novartis AG has filed alongside them.

FY2025 annual
Net Income $14.0B
YoY +17.0%
5Y CAGR +11.6%
10Y CAGR -2.4%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NVS Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Net Income$14.0B+17.0%$11.9B-19.6%$14.9B+113.6%$7.0B-71.0%$24.0B+197.6%$8.1B-31.2%$11.7B-7.0%$12.6B+63.8%$7.7B+15.0%$6.7B-62.4%$17.8B

NVS Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ2'2510-QQ4'2410-KQ2'2410-QQ4'2310-KQ2'2310-QQ4'2210-KQ2'2210-QQ4'2110-KQ2'2110-QQ4'2010-KQ2'2010-Q
Net IncomeN/A$4.0B+24.0%N/A$3.2B+40.1%N/A$2.3B+36.7%N/A$1.7B-41.5%N/A$2.9B+55.1%N/A$1.9B-72.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Novartis AG financials

Frequently Asked Questions

What was Novartis AG's net income in fiscal year 2025?

Novartis AG reported $14.0B in net income in fiscal year 2025.

How fast is Novartis AG's net income growing?

Novartis AG (NVS) net income rose by 17.0% year over year, from $11.9B to $14.0B in fiscal year 2025.

How has Novartis AG's net income changed over the years?

Across the 11 fiscal years this page covers, Novartis AG (NVS) net income went from $17.8B in fiscal year 2015 to $14.0B in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Novartis AG (NVS) reported on that line in every period on record.